Neuroscience
Britain is bottom of Euro league table at diagnosing Alzheimer's
Britons with symptoms of Alzheimer’s disease take twice as long to be diagnosed as sufferers living in other European countries, research has found.
By Laura Donnelly, Health Correspondent
The Telegraph
9:00PM GMT 26 Feb 2011
Read the article
- Alzheimer's Disease: Phase Ii Gammagard Findings
A report from the Alzheimer's Association International Conference (AAIC) in Vancouver: Alzheimer's drug IVIg could halt sufferers' decline Trial involving 16 patients excites scientists by suggesting treatment prevented deterioration of memory...
- Alzheimer's: The Current Pipeline
FierceBiotechResearch has an article which presents a very brief overview of the current Alzheimer's disease drug pipeline: It is available at the link below: Making sense of the Alzheimer's drug pipeline FierceBiotechResearch March 15, 2011 —...
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Alzheimer's Disease: Advances In Genetic Understanding
A report from The Guardian about ongoing genetics research in Alzheimer's disease: Alzheimer's research links three genes to disease Findings hailed as 'huge step' towards earlier testing and better treatment for Alzheimer's Ian Sample,...
- Upcoming Event: Alzheimer Disease (las Vegas, 29-30 Oct 2009)
2nd Conference on Clinical Trials on Alzheimer’s Disease (CTAD) From the conference website: "Dear Colleague, "It is a great pleasure for us to invite you to attend the 2nd conference Clinical Trials on Alzheimer’s Disease (CTAD), which will take...
Neuroscience
Alzheimer's: Differences in Diagnostic Trends
Britain is bottom of Euro league table at diagnosing Alzheimer's
Britons with symptoms of Alzheimer’s disease take twice as long to be diagnosed as sufferers living in other European countries, research has found.
By Laura Donnelly, Health Correspondent
The Telegraph
9:00PM GMT 26 Feb 2011
Read the article
- Alzheimer's Disease: Phase Ii Gammagard Findings
A report from the Alzheimer's Association International Conference (AAIC) in Vancouver: Alzheimer's drug IVIg could halt sufferers' decline Trial involving 16 patients excites scientists by suggesting treatment prevented deterioration of memory...
- Alzheimer's: The Current Pipeline
FierceBiotechResearch has an article which presents a very brief overview of the current Alzheimer's disease drug pipeline: It is available at the link below: Making sense of the Alzheimer's drug pipeline FierceBiotechResearch March 15, 2011 —...
- Fda: Pcns Drugs Advisory Committee Results For Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
A fuller report from The New York Times: F.D.A. Sees Promise in Alzheimer’s Imaging Drug By GINA KOLATA The New York Times Published: January 20, 2011 "A committee voted that the agency should approve the first test that can show the characteristic...
- Alzheimer's Disease: Advances In Genetic Understanding
A report from The Guardian about ongoing genetics research in Alzheimer's disease: Alzheimer's research links three genes to disease Findings hailed as 'huge step' towards earlier testing and better treatment for Alzheimer's Ian Sample,...
- Upcoming Event: Alzheimer Disease (las Vegas, 29-30 Oct 2009)
2nd Conference on Clinical Trials on Alzheimer’s Disease (CTAD) From the conference website: "Dear Colleague, "It is a great pleasure for us to invite you to attend the 2nd conference Clinical Trials on Alzheimer’s Disease (CTAD), which will take...